Sign In
Buy CERT
$5.60
-0.0200 (-0.356%)
At Close: Jun 03, 2026
Why Certara's Shares Rose 37.7% This Week
04:28pm, Friday, 11'th Nov 2022
The company, which helps other companies in their drug development, reported strong third-quarter numbers.
Certara, Inc. (CERT) Q3 Earnings Miss Estimates
08:19pm, Monday, 07'th Nov 2022
Certara, Inc. (CERT) delivered earnings and revenue surprises of -9.09% and 2.84%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Certara Inc. (CERT) Q3 2022 Earnings Call Transcript
07:49pm, Monday, 07'th Nov 2022
Certara Inc. (NASDAQ:CERT ) Q3 2022 Results Conference Call November 7, 2022 5:00 PM ET Company Participants David Deuchler - IR William Feehery - CEO Andrew Schemick - CFO Conference Call Participant
Certara to Participate in Upcoming Investor Conferences
05:00pm, Wednesday, 02'nd Nov 2022
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor co
Certara to Report Third Quarter 2022 Financial Results on November 7th, 2022
07:45am, Thursday, 13'th Oct 2022
PRINCETON, N.J., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2022
Certara to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 31'st Aug 2022
PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor co
Here's Why Certara Stock Is Falling Friday
09:45am, Friday, 12'th Aug 2022
Certara Inc (NASDAQ: CERT) shares are trading lower by 15.40% to $17.08 Friday morning after the company announced a secondary offering of 7 million shares of common stock. What Else?
Certara, Inc. (CERT) Q2 Earnings and Revenues Miss Estimates
09:04pm, Tuesday, 09'th Aug 2022
Certara, Inc. (CERT) delivered earnings and revenue surprises of -18.18% and 3.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Certara, Inc.'s (CERT) CEO William Feehery on Q1 2022 Results - Earnings Call Transcript
04:12am, Sunday, 08'th May 2022
Certara, Inc. (NASDAQ:CERT ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants David Deuchler – Investor Relations William Feehery – Chief Executive Officer Andrew Schem
Certara, Inc. (CERT) Matches Q1 Earnings Estimates
08:18pm, Thursday, 05'th May 2022
Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 2.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Certara to Report First Quarter 2022 Financial Results on May 5th, 2022
08:00am, Wednesday, 20'th Apr 2022
PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2022
Certara, Inc. (CERT) Soars 6.1%: Is Further Upside Left in the Stock?
11:17am, Thursday, 17'th Mar 2022
Certara, Inc. (CERT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increa
Certara, Inc. (CERT) CEO William Feehery on Q4 2021 Results - Earnings Call Transcript
10:44pm, Tuesday, 01'st Mar 2022
Certara, Inc. (CERT) CEO William Feehery on Q4 2021 Results - Earnings Call Transcript
Certara, Inc. (CERT) Q4 Earnings and Revenues Lag Estimates
07:55pm, Tuesday, 01'st Mar 2022
Certara, Inc. (CERT) delivered earnings and revenue surprises of -88.89% and 8.47%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
04:30pm, Tuesday, 08'th Feb 2022
PRINCETON, N.J., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and ful
